Monoclonal Antibody Therapy
Monoclonal antibody therapy is used to treat COVID-19 in non-hospitalized people 12 years of age or older with mild to moderate symptoms AND who are at high risk for developing severe symptoms or being hospitalized.
This therapy contains human-made antibodies to help fight COVID-19. It does NOT contain any COVID-19 virus.
In a clinical trial, scientists found that people who received monoclonal antibodies within 10 days of COVID-19 symptoms starting were less likely to be admitted to the hospital.